Document Detail


Non-nicotine pharmacotherapies for smoking cessation.
MedLine Citation:
PMID:  16011894     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
International chronic obstructive pulmonary disease guidelines recommend that smokers be strongly advised to quit, and should be offered help in doing so. The most effective smoking-cessation interventions combine behavioural support with pharmacotherapies. For smokers who do not wish to use nicotine replacement treatments, bupropion is a safe and effective non-nicotine alternative first-line treatment. Nortriptyline and clonidine have demonstrated efficacy in aiding smoking cessation, but are regarded as second-line therapies. A number of other non-nicotine treatments show promise, but more data are required before these can be recommended in assisting smokers to stop.
Authors:
H McRobbie; M Lee; Z Juniper
Related Documents :
21307034 - Narrative possibilities: poor women of color and the complexities of intimate partner v...
14660114 - A study of environmental tobacco smoke in south australian pubs, clubs and cafes.
7086634 - Cigarette smoking, nicotine addiction, and relaxation.
19339124 - Features of men with anabolic-androgenic steroid dependence: a comparison with nondepen...
20510334 - Uptake of wetting method in africa to reduce cyanide poisoning and konzo from cassava.
17658694 - Effects of acute ovarian hormone suppression on the human brain: an in vivo 1h mrs study.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Respiratory medicine     Volume:  99     ISSN:  0954-6111     ISO Abbreviation:  Respir Med     Publication Date:  2005 Oct 
Date Detail:
Created Date:  2005-09-05     Completed Date:  2006-03-06     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8908438     Medline TA:  Respir Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  1203-12     Citation Subset:  IM    
Affiliation:
Tobacco Dependence Research and Treatment Centre, Barts and The London, Queen Mary's School of Medicine and Dentistry, Turner Street, London E1 2AD, UK. h.mcrobbie@ctru.auckland.ac.nz
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenergic alpha-Agonists / therapeutic use
Antidepressive Agents, Tricyclic / therapeutic use
Bupropion / therapeutic use
Clonidine / therapeutic use
Dopamine Uptake Inhibitors / therapeutic use
Humans
Nortriptyline / therapeutic use
Randomized Controlled Trials as Topic
Smoking / drug therapy*,  prevention & control
Smoking Cessation / methods*
Chemical
Reg. No./Substance:
0/Adrenergic alpha-Agonists; 0/Antidepressive Agents, Tricyclic; 0/Dopamine Uptake Inhibitors; 34841-39-9/Bupropion; 4205-90-7/Clonidine; 72-69-5/Nortriptyline

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and noni...
Next Document:  Tracheobronchial haemorrhage in patients with neuromuscular disorders.